Cleared Traditional

K160757 - ADVIA Centaur Active-B12 (Holotranscobalamin)(AB12) Assay, ADVIA Centaur Active-B12(AB12) Quality Control, and ADVIA Centaur Active-B12 (AB12) Master Curve Materials (MCM) (FDA 510(k) Clearance)

Jul 2016
Decision
130d
Days
Class 2
Risk

K160757 is an FDA 510(k) clearance for the ADVIA Centaur Active-B12 (Holotranscobalamin)(AB12) Assay, ADVIA Centaur Active-B12(AB12) Quality Control, and ADVIA Centaur Active-B12 (AB12) Master Curve Materials (MCM). This device is classified as a Radioassay, Vitamin B12 (Class II - Special Controls, product code CDD).

Submitted by Axis-Shield Diagnostics Limited (Dundee, Scotland, GB). The FDA issued a Cleared decision on July 26, 2016, 130 days after receiving the submission on March 18, 2016.

This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 862.1810.

Submission Details

510(k) Number K160757 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 18, 2016
Decision Date July 26, 2016
Days to Decision 130 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF

Device Classification

Product Code CDD - Radioassay, Vitamin B12
Device Class Class II - Special Controls
CFR Regulation 21 CFR 862.1810